Application | Comment | Organism |
---|---|---|
molecular biology | results display the requirement of RSK activity during Artemia development and suggest its role in termination of cell cycle (G2/Mphase) arrest and promotion of mitogenesis | Artemia parthenogenetica |
Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli | Artemia parthenogenetica |
Protein Variants | Comment | Organism |
---|---|---|
additional information | in vivo knockdown of RSK activity by RNA interference, kinase inhibition, and antibody neutralization consistently induced defective larvae with distinct gaps between the exoskeleton and internal tissues. In these abnormal individuals, mitoses are detected to be largely inhibited in the affected regions | Artemia parthenogenetica |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Artemia parthenogenetica | B0EXJ4 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
embryo | - |
Artemia parthenogenetica | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
using immunochemistry, morphology, and cell cycle analysis, the identified Artemia RSK is established to be specifically activated during the post-embryonic and early larval developmental stages when arrested cells of encysted embryos resume mitoses | Artemia parthenogenetica |
Synonyms | Comment | Organism |
---|---|---|
p90 ribosomal S6 kinase | - |
Artemia parthenogenetica |
RSK | - |
Artemia parthenogenetica |